S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
Options Trading Plan–Perfect For Beginners (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
Options Trading Plan–Perfect For Beginners (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
Options Trading Plan–Perfect For Beginners (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
BREAKING: Tiny biotech successfully treats blindness (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
Options Trading Plan–Perfect For Beginners (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
NASDAQ:XELA

Exela Technologies (XELA) Stock Forecast, Price & News

$3.54
+0.02 (+0.57%)
(As of 09/20/2023 ET)
Compare
Today's Range
$3.46
$3.79
50-Day Range
$3.52
$6.50
52-Week Range
$2.62
$125.80
Volume
246,291 shs
Average Volume
140,568 shs
Market Capitalization
$22.55 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

XELA stock logo

About Exela Technologies (NASDAQ:XELA) Stock

Exela Technologies Inc is a global leader in business process automation and information management solutions. The company is headquartered in Irving, Texas, was founded in 2017 and operates in over 50 countries. Exela helps its clients to streamline their business operations, reduce costs and improve customer engagement through its proprietary platform and suite of solutions.

The company's services include document management, payment processing, human resources management and customer care. Exela's clients come from diverse industries, including healthcare, finance, insurance and government.

Exela has been recognized for its excellence in information management, having won numerous awards for its innovative solutions. The company was named a "Leader" in the Gartner Magic Quadrant for Intelligent Business Process Management Suites in 2020.

Exela's leadership team comprises experienced professionals with a wealth of knowledge in business process automation and information management knowledge. Ron Cogburn serves as the company's CEO and Chairman of the Board. Cogburn has over 30 years of experience in the technology industry and has held leadership positions at several successful companies. He is committed to driving innovation and growth at Exela.

Exela Technologies Inc has seen steady revenue over the past few years, with revenues ranging between $250 million and $300 million. Exela's profit margins have remained relatively stable over the past few years, with average gross margins of 35.5% and a net margin averaging around -10%. The company's debt levels have decreased slightly over the past several years, insinuating an effort to pay down liabilities. However, it is essential to note that Exela Technologies' price-to-earnings ratio and price-to-book ratios are significantly lower than the industry averages. Exela's stock price has experienced significant volatility over the past few years. The company's trading volume has also been extremely high, with an average of 190 million shares traded daily over the past several years.

Exela operates in the highly competitive business process automation and information management field. The industry is driven by technological advancements and growing demand for more efficient and cost-effective business solutions.

Exela's competitors include large technology companies such as IBM, Accenture, DXC Technology and smaller, specialized firms. The industry is also subject to regulatory and political pressures, particularly data privacy and security issues.

Exela Technologies Inc has several growth opportunities, including expanding its product offerings and entering new markets. The company has recently launched several new solutions, including Digital Mailroom and Workflow Automation, which have received positive customer feedback.

Exela is also exploring opportunities to expand into new markets, particularly in Asia and Europe. The company has established partnerships with several leading technology firms to support its expansion efforts, including a recent collaboration with Infosys to develop solutions for the insurance industry.

In addition, Exela has made several strategic acquisitions in recent years to enhance its capabilities and expand its customer base. In 2020, the company acquired Asterion, a provider of secure data management solutions and in 2019, it received Conduent's commercial healthcare provider solutions business.

Like any company, Exela Technologies Inc faces several risks and challenges that could impact its performance. One of the biggest challenges for the company is the competitive nature of the industry. Exela competes with both large technology companies and smaller, specialized firms and must continue to innovate to stay ahead.

Another challenge for Exela is the ongoing regulatory and political pressure around data privacy and security issues. The company must ensure that its solutions comply with relevant regulations and is prepared to respond to any regulation changes.

Exela must continue to adapt to changing customer preferences and market conditions. The COVID-19 pandemic, for example, accelerated the shift to remote work and digital solutions, which could impact the demand for some of Exela's services.

XELA Price History

XELA Stock News Headlines

Q2 2023 Exela Technologies Inc Earnings Call
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
30 Days of MarketBeat All Access Free
Access our premier stock research platform that includes research tools, stock screeners, instant alerts, real-time news and much more.
See More Headlines
Receive XELA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exela Technologies and its competitors with MarketBeat's FREE daily newsletter.

XELA Company Calendar

Last Earnings
8/14/2023
Today
9/20/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:XELA
Fax
N/A
Employees
16,000
Year Founded
N/A

Profitability

Net Income
$-415,580,000.00
Pretax Margin
-37.31%

Debt

Sales & Book Value

Annual Sales
$1.08 billion
Book Value
($579.63) per share

Miscellaneous

Free Float
6,367,000
Market Cap
$22.55 million
Optionable
Not Optionable
Beta
1.70
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Suresh Yannamani (Age 51)
    President
  • Ronald Clark Cogburn (Age 61)
    Chief Executive Officer, Director
  • Jim Reynolds (Age 48)
    Chief Financial Officer, Director
  • Mark FairchildMark Fairchild (Age 57)
    President, Exela Enterprise Solutions
  • Shrikant SorturShrikant Sortur (Age 44)
    Executive Vice President - Global Finance
  • Joshua M. Black (Age 30)
    Director
  • Par ChadhaPar Chadha (Age 62)
    Director
  • Gordon J. Coburn (Age 53)
    Director
  • Nathaniel J. Lipman (Age 53)
    Director
  • Matthew H. Nord (Age 38)
    Director













XELA Stock - Frequently Asked Questions

How have XELA shares performed in 2023?

Exela Technologies' stock was trading at $16.40 at the beginning of the year. Since then, XELA shares have decreased by 78.4% and is now trading at $3.54.
View the best growth stocks for 2023 here
.

When is Exela Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our XELA earnings forecast
.

How were Exela Technologies' earnings last quarter?

Exela Technologies, Inc. (NASDAQ:XELA) released its quarterly earnings results on Monday, August, 14th. The company reported ($5.19) EPS for the quarter. The company earned $272.94 million during the quarter.

What ETF holds Exela Technologies' stock ?

Direxion Work From Home ETF holds 72,767 shares of XELA stock, representing 1.36% of its portfolio.

When did Exela Technologies' stock split?

Shares of Exela Technologies reverse split before market open on Monday, May 15th 2023. The 1-200 reverse split was announced on Monday, May 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, May 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split.

What is Ron Cogburn's approval rating as Exela Technologies' CEO?

140 employees have rated Exela Technologies Chief Executive Officer Ron Cogburn on Glassdoor.com. Ron Cogburn has an approval rating of 46% among the company's employees. This puts Ron Cogburn in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Exela Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exela Technologies investors own include Biocept (BIOC), Acasti Pharma (ACST), Avinger (AVGR), Bionano Genomics (BNGO), Heat Biologics (HTBX), T2 Biosystems (TTOO), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK), AgEagle Aerial Systems (UAVS).

What is Exela Technologies' stock symbol?

Exela Technologies trades on the NASDAQ under the ticker symbol "XELA."

Who are Exela Technologies' major shareholders?

Exela Technologies' stock is owned by a number of institutional and retail investors. Top institutional investors include Shay Capital LLC (0.00%), BlackRock Inc. (1.10%), Geode Capital Management LLC (0.80%), Simplex Trading LLC (0.00%), Belvedere Trading LLC (0.00%) and Citadel Advisors LLC (0.00%). Insiders that own company stock include Marc A Beilinson, Mark D Fairchild, Par Chadha, Shrikant Sortur and William L Transier.
View institutional ownership trends
.

How do I buy shares of Exela Technologies?

Shares of XELA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Exela Technologies' stock price today?

One share of XELA stock can currently be purchased for approximately $3.54.

How much money does Exela Technologies make?

Exela Technologies (NASDAQ:XELA) has a market capitalization of $22.55 million and generates $1.08 billion in revenue each year.

How many employees does Exela Technologies have?

The company employs 16,000 workers across the globe.

How can I contact Exela Technologies?

Exela Technologies' mailing address is 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061. The official website for the company is www.exelatech.com. The company can be reached via phone at 844-935-2832 or via email at ir@exelatech.com.

This page (NASDAQ:XELA) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -